PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity

Title
PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity
Authors
Keywords
CD4+ T-cell epitope prediction, Epitope-based vaccination, Immunodominance, MHC (HLA) class II proteins, MHC (HLA) class II polymorphism, Pan-specific, Peptide binding prediction, Peptide vaccination, Specificity-determining residues
Journal
BMC BIOINFORMATICS
Volume 14, Issue 1, Pages 52
Publisher
Springer Nature
Online
2013-02-15
DOI
10.1186/1471-2105-14-52

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started